Invasive breast lobular carcinoma
Clinical trials for Invasive breast lobular carcinoma explained in plain language.
Never miss a new study
Get alerted when new Invasive breast lobular carcinoma trials appear
Sign up with your email to follow new studies for Invasive breast lobular carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, given alone or with the immunotherapy drug pembrolizumab. The goal is to see if the combination is safe and helps the immune system attack advanced solid tumors. About 132 people with various advanc…
Matched conditions: INVASIVE BREAST LOBULAR CARCINOMA
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New drug combo shows promise for rare breast cancer type
Disease control Recruiting nowThis phase II trial is testing whether the drug neratinib, given before standard treatment, can improve outcomes for people with stage I-III HER2-mutated lobular breast cancer. Neratinib blocks a protein that helps cancer cells grow. The study will enroll 30 participants and meas…
Matched conditions: INVASIVE BREAST LOBULAR CARCINOMA
Phase 2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC